176 related articles for article (PubMed ID: 20693542)
1. Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study.
Biegstraaten M; Mengel E; Maródi L; Petakov M; Niederau C; Giraldo P; Hughes D; Mrsic M; Mehta A; Hollak CE; van Schaik IN
Brain; 2010 Oct; 133(10):2909-19. PubMed ID: 20693542
[TBL] [Abstract][Full Text] [Related]
2. Are symptoms of peripheral neuropathy more prevalent in patients with Gaucher disease?
Halperin A; Elstein D; Zimran A
Acta Neurol Scand; 2007 Apr; 115(4):275-8. PubMed ID: 17376127
[TBL] [Abstract][Full Text] [Related]
3. [Peripheral neuropathy associated with chronic obstructive pulmonary disease].
Poza JJ; Martí-Massó JF
Neurologia; 1997 Nov; 12(9):389-94. PubMed ID: 9471176
[TBL] [Abstract][Full Text] [Related]
4. The at-risk foot concerns not only patients with diabetes mellitus.
Pataky Z; Herrmann FR; Regat D; Vuagnat H
Gerontology; 2008; 54(6):349-53. PubMed ID: 18446046
[TBL] [Abstract][Full Text] [Related]
5. [Study of the onset and progression of peripheral neuropathy and hypertension in NIDDM].
Jarmuzewska EA; Ghidoni A
Minerva Med; 2000; 91(1-2):1-15. PubMed ID: 10858728
[TBL] [Abstract][Full Text] [Related]
6. Miglustat (Zavesca) in type 1 Gaucher disease: 5-year results of a post-authorisation safety surveillance programme.
Hollak CE; Hughes D; van Schaik IN; Schwierin B; Bembi B
Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):770-7. PubMed ID: 19507165
[TBL] [Abstract][Full Text] [Related]
7. Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic.
Zimran A; Liphshitz I; Barchana M; Abrahamov A; Elstein D
Blood Cells Mol Dis; 2005; 34(3):197-200. PubMed ID: 15885601
[TBL] [Abstract][Full Text] [Related]
8. Overweight, insulin resistance and type II diabetes in type I Gaucher disease patients in relation to enzyme replacement therapy.
Langeveld M; de Fost M; Aerts JM; Sauerwein HP; Hollak CE
Blood Cells Mol Dis; 2008; 40(3):428-32. PubMed ID: 17950007
[TBL] [Abstract][Full Text] [Related]
9. [Course of chronic idiopathic polyneuropathy during middle age and older: 2-year follow-up study].
Notermans NC; Wokke JH; Franssen H; Vermeulen M; Busch HF; Jennekens FG
Ned Tijdschr Geneeskd; 1994 Jun; 138(25):1281-5. PubMed ID: 8022510
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
11. The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India.
van Brakel WH; Nicholls PG; Das L; Barkataki P; Suneetha SK; Jadhav RS; Maddali P; Lockwood DN; Wilder-Smith E; Desikan KV
Lepr Rev; 2005 Mar; 76(1):14-34. PubMed ID: 15881033
[TBL] [Abstract][Full Text] [Related]
12. Increased incidence of cancer in adult Gaucher disease in Western Europe.
de Fost M; Vom Dahl S; Weverling GJ; Brill N; Brett S; Häussinger D; Hollak CE
Blood Cells Mol Dis; 2006; 36(1):53-8. PubMed ID: 16246599
[TBL] [Abstract][Full Text] [Related]
13. Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy.
Kauli R; Zaizov R; Lazar L; Pertzelan A; Laron Z; Galatzer A; Phillip M; Yaniv Y; Cohen IJ
Isr Med Assoc J; 2000 Feb; 2(2):158-63. PubMed ID: 10804944
[TBL] [Abstract][Full Text] [Related]
14. The clinical course of untreated Gaucher disease in 22 patients over 10 years: hematological and skeletal manifestations.
Piran S; Roberts A; Patterson MA; Amato D
Blood Cells Mol Dis; 2009; 43(3):289-93. PubMed ID: 19793665
[TBL] [Abstract][Full Text] [Related]
15. Peripheral neuropathy in patients with the 3243A>G mutation in mitochondrial DNA.
Kärppä M; Syrjälä P; Tolonen U; Majamaa K
J Neurol; 2003 Feb; 250(2):216-21. PubMed ID: 12574954
[TBL] [Abstract][Full Text] [Related]
16. An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment.
Pastores GM; Barnett NL; Kolodny EH
Clin Ther; 2005 Aug; 27(8):1215-27. PubMed ID: 16199246
[TBL] [Abstract][Full Text] [Related]
17. Peripheral neuropathy in myotonic dystrophy: electrophysiological and clinical features.
Logullo F; Censori B; Danni M; Del Pesce M; Di Bella P; Provinciali L
Electromyogr Clin Neurophysiol; 1992; 32(10-11):515-20. PubMed ID: 1332841
[TBL] [Abstract][Full Text] [Related]
18. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
19. Neurofibromatosis 1-associated neuropathies: a reappraisal.
Drouet A; Wolkenstein P; Lefaucheur JP; Pinson S; Combemale P; Gherardi RK; Brugières P; Salama J; Ehre P; Decq P; Créange A
Brain; 2004 Sep; 127(Pt 9):1993-2009. PubMed ID: 15289270
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
